JP2009538282A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538282A5 JP2009538282A5 JP2009511015A JP2009511015A JP2009538282A5 JP 2009538282 A5 JP2009538282 A5 JP 2009538282A5 JP 2009511015 A JP2009511015 A JP 2009511015A JP 2009511015 A JP2009511015 A JP 2009511015A JP 2009538282 A5 JP2009538282 A5 JP 2009538282A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- ngr1
- amino acids
- item
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80000806P | 2006-05-15 | 2006-05-15 | |
| PCT/US2007/011557 WO2007133746A2 (en) | 2006-05-15 | 2007-05-15 | Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538282A JP2009538282A (ja) | 2009-11-05 |
| JP2009538282A5 true JP2009538282A5 (https=) | 2010-07-08 |
Family
ID=38694527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009511015A Pending JP2009538282A (ja) | 2006-05-15 | 2007-05-15 | 乏突起膠細胞の生存を促進させるためのNogo受容体−1(NgR1)アンタゴニストの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20110123535A1 (https=) |
| EP (1) | EP2023735A4 (https=) |
| JP (1) | JP2009538282A (https=) |
| WO (1) | WO2007133746A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2081429A4 (en) * | 2006-08-31 | 2010-01-06 | Biogen Idec Inc | PROCESS FOR PERIPHERAL ADMINISTRATION OF NOGO RECEPTOR POLYPEPTIDES |
| EP2276500A4 (en) * | 2008-03-13 | 2015-03-04 | Univ Yale | REACTIVATION OF AXON GROWTH AND AXON RECOVERY IN CHRONIC REVERSE MARKET INJURIES |
| AU2016270373A1 (en) | 2015-06-05 | 2018-01-04 | Vertex Pharmaceuticals Incorporated | Triazoles for the treatment of demyelinating diseases |
| WO2018106641A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Pyrazoles for the treatment of demyelinating diseases |
| WO2018106646A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Aminotriazoles for the treatment of demyelinating diseases |
| WO2018106643A1 (en) | 2016-12-06 | 2018-06-14 | Vertex Pharmaceuticals Incorporated | Heterocyclic azoles for the treatment of demyelinating diseases |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1341050C (en) * | 1988-11-04 | 2000-07-11 | Martin E. Schwab | Neurite growth regulatory factors |
| DE68923362T2 (de) * | 1988-11-04 | 1996-03-28 | Zuerich Erziehungsdirektion | Wachstumsregelfaktoren für neuriten. |
| US5250414A (en) * | 1988-11-04 | 1993-10-05 | Erziehungsdirektion Of The Canton Zurich | Diagnostic methods using neurite growth regulatory factors |
| US6031072A (en) * | 1996-07-12 | 2000-02-29 | Mcgill University | Compounds and methods for modulating cell adhesion |
| US5858708A (en) * | 1996-08-12 | 1999-01-12 | Bandman; Olga | Polynucleotides encoding two novel human neuroendocrine-specific proteins |
| WO1999066041A1 (en) * | 1998-06-16 | 1999-12-23 | Human Genome Sciences, Inc. | 94 human secreted proteins |
| US7041474B2 (en) * | 1998-12-30 | 2006-05-09 | Millennium Pharmaceuticals, Inc. | Nucleic acid encoding human tango 509 |
| US7119165B2 (en) * | 2000-01-12 | 2006-10-10 | Yale University | Nogo receptor-mediated blockade of axonal growth |
| IL150566A0 (en) * | 2000-01-12 | 2003-02-12 | Univ Yale | Nucleic acids and polypeptides and nogo-receptor proteins |
| NZ525422A (en) * | 2000-10-06 | 2006-09-29 | Biogen Idec Inc | Isolated polynucleotides comprising a nucleic acid which encodes a polypeptide which modulates axonal growth in CNS neurons |
| WO2003035687A1 (en) * | 2001-10-22 | 2003-05-01 | Novartis Ag | Nogo receptor homologues and their use |
| US7309485B2 (en) * | 2001-12-03 | 2007-12-18 | Children's Medical Center Corporation | Reducing myelin-mediated inhibition of axon regeneration |
| US20030113325A1 (en) * | 2001-12-03 | 2003-06-19 | Zhigang He | Reducing myelin-mediated inhibition of axon regeneration |
| US7745151B2 (en) * | 2002-08-02 | 2010-06-29 | Children's Medical Center Corporation | Methods of determining binding between Nogo receptor and p75 neurotrophin receptor |
| PT1534736E (pt) * | 2002-08-10 | 2010-09-07 | Univ Yale | Antagonistas do receptor nogo |
| US20080274112A1 (en) * | 2003-08-07 | 2008-11-06 | Lee Daniel H S | Nogo Receptor Antagonists |
| PT1776136E (pt) * | 2004-06-24 | 2012-12-05 | Biogen Idec Inc | Tratamento de estados que envolvem desmielinização |
| FR2900996B1 (fr) * | 2006-05-12 | 2008-08-08 | Skf Ab | Cage pour roulement a billes |
-
2007
- 2007-05-15 JP JP2009511015A patent/JP2009538282A/ja active Pending
- 2007-05-15 EP EP07777039A patent/EP2023735A4/en not_active Withdrawn
- 2007-05-15 US US12/300,933 patent/US20110123535A1/en not_active Abandoned
- 2007-05-15 WO PCT/US2007/011557 patent/WO2007133746A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011503069A5 (https=) | ||
| AU2021236674B2 (en) | Compositions and methods for inhibiting ANGPTL3 expression | |
| KR102728481B1 (ko) | Lpa의 유전자 발현을 저해하기 위한 조성물 및 방법 | |
| Theis et al. | Lentiviral delivery of miR-133b improves functional recovery after spinal cord injury in mice | |
| US7205387B2 (en) | Recombinant polypeptide useful for neurotrophin receptor mediated gene delivery and as neurotrophin agonist | |
| JP2009538282A5 (https=) | ||
| JP2009518299A5 (https=) | ||
| RS57467B1 (sr) | Oligonukleotidni analozi koji ciljaju humani lmna | |
| CN113272426A (zh) | 用于尿素循环蛋白和核酸的替代的细胞外囊泡 | |
| JP2008504297A5 (https=) | ||
| CN104039357A (zh) | 胰腺β-细胞增殖的调节 | |
| CN102356156A (zh) | 用于治疗神经退行性疾病或与细胞周期未预期激活相关疾病的包含编码cdk4/cdk6抑制子的诱导型基因的载体 | |
| JP2023538630A (ja) | B型肝炎ウイルス感染症を処置するためのa1cf阻害剤の使用 | |
| JP2011504375A (ja) | 細胞の中に核酸を導入する医薬組成物及びその方法 | |
| US9493772B2 (en) | Method for reducing expression of downregulated in renal cell carcinoma in malignant gliomas | |
| TW200914052A (en) | RNAi-related inhibition of TNFα signaling pathway for treatment of glaucoma | |
| US20240294907A1 (en) | Selective delivery of oligonucleotides to glial cells | |
| JP2025094072A (ja) | B型肝炎ウイルス感染を処置するためのcops3阻害剤の使用 | |
| US20220033470A1 (en) | Compositions Comprising Sortilin-1 | |
| JP2013534410A6 (ja) | 悪性神経膠腫においてdown regulated in renal cell carcinomaの発現を減少させる方法 | |
| US20230416743A1 (en) | Compositions and methods for inhibiting snca expression | |
| WO2024178223A1 (en) | Antisense oligonucleotides for preventing unc13a misplicing | |
| CN120936359A (zh) | 用于抑制胸腺基质淋巴细胞生成素(TSLP)表达的RNAi试剂、其组合物和使用方法 | |
| US7256284B2 (en) | Inhibitory oligonucleotides targeted to Bcl-2 | |
| US7666676B2 (en) | Modulating cancer cell characteristics |